The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).

Clinical trial NCT00385203 · COMPLETED

Trial details

NCT number: NCT00385203
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors Soft Tissue Sarcomas

Start date: 2006-09-01
Primary completion: 2008-06-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.